Rate My Professor Dee Mangin

Professor Dee Mangin holds the position of Professor of General Practice at the University of Otago, Christchurch, in the Faculty of Medicine's Department of Primary Health Care. A graduate of the University of Otago with degrees MBChB and DPH, she is also a Fellow of the Royal New Zealand College of General Practitioners (FRNZCGP). Mangin's professional journey began as a general practitioner in Christchurch. She advanced to become Director of the Primary Care Unit and Clinical Leader for Research, Audit, and Evaluation at Pegasus Health Primary Healthcare Organisation. In 2016, she was promoted to full professor at Otago. Concurrently, since relocating to Canada in 2013, she serves as Professor of Family Medicine at McMaster University, where she previously held the David Braley Nancy Gordon Chair in Family Medicine for ten years, acted as Associate Chair for Research in the Department of Family Medicine, and directs the McMaster University Sentinel and Information Collaboration (M.U.S.I.C.). She was a ministerially appointed member of the New Zealand Pharmaceutical and Therapeutic Products Advisory Committee (PHARMAC).

Her research specializations encompass rational prescribing, the impacts of science, policy, and commerce on healthcare, pharmaceutical policy, evidence-based medicine, primary care research methodologies, and patient safety. Current academic interests include multimorbidity and polypharmacy management, deprescribing interventions for older adults, innovative primary care delivery models, and enhancing generalist care value in education and health systems. Mangin has authored numerous influential publications, such as the highly cited "Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy" (2010, Archives of Internal Medicine, 856 citations), "Challenges and enablers of deprescribing: a general practitioner perspective" (2016, PLOS ONE, 251 citations), "International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement" (2018, Drugs & Aging), and "Maintenance or discontinuation of antidepressants in primary care" (2021, New England Journal of Medicine). Recent works include studies on multimorbidity interventions (2025, Family Practice) and serotonin reuptake inhibitors (2025). She has earned prestigious awards including the RNZCGP Distinguished Service Medal (2012), the Canadian College of Family Physicians Donald I Rice Award for leadership (2018), and Researcher of the Year (2023). Additionally, she co-founded RxISK.org for adverse drug reaction reporting and contributes to national and international committees on patient safety and primary care research, significantly impacting clinical practice and policy on medication safety and optimization.